Science Explorer Back to mapMap
Discussion
Researcher · Eisai (United Kingdom) · United Kingdom

Begoña de las Heras

Begoña de las Heras publishes mostly in Oncology, Epidemiology and Hepatology, on topics such as Hepatitis B Virus Studies, Hepatitis C virus research and Thyroid Cancer Diagnosis and Treatment.

ORCID 0000-0003-3091-1684 OpenAlex
World rank
#3,209,660
of 7,710,434 ranked researchers
Rank in United Kingdom
#215,835
of 367,258
Works
48
Citations
2.7k
Citations per work
55.4
h-index
13
i10-index 15Top 44% in Oncology
Begoña de las Heras

What does Begoña de las Heras research?

Begoña de las Heras's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 26 works · 54.6% of their workMedicine: 26 works · 54.6% of their workOncology: 12 works · 25.6% of their workEpidemiology: 5 works · 10.0% of their workHepatology: 4 works · 7.8% of their workEndocrinology, Diabetes and Metabolism: 3 works · 5.6% of their workSurgery: 3 works · 5.6% of their workEverything else: 19 works · 38.7% of their workLife Sciences: 3 works · 6.7% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 6.7% of their workMolecular Biology: 3 works · 6.7% of their workTHEIR WORKBegoña de lasHeras48works
Life Sciences7%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2654.6%
  2. Everything else1938.7%
    1. Biochemistry, Genetics and Molecular Biology36.7%
  1. 1Oncology26% of their works
  2. 2Epidemiology10% of their works
  3. 3Hepatology8% of their works
  4. 4Molecular Biology7% of their works
  5. 5Surgery6% of their works
  6. 6Endocrinology, Diabetes and Metabolism6% of their works

Research topics

Which keywords describe Begoña de las Heras's research?

The keywords of their largest research topics: Antiviral Therapy, Liver Disease, Hepatocellular Carcinoma, Genetic Variation, Chronic Hepatitis B, Hepatitis B Virus, Hepatitis C Virus and Treatment.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Antiviral Therapy102 topics
  2. Liver Disease102 topics
  3. Hepatocellular Carcinoma82 topics
  4. Genetic Variation72 topics
  5. Chronic Hepatitis B51 topic
  6. Hepatitis B Virus51 topic
  7. Hepatitis C Virus51 topic
  8. Treatment51 topic
  9. COVID-1941 topic
  10. Cancer41 topic
  11. Chemotherapy-Induced Peripheral Neuropathy41 topic
  12. Differentiated Thyroid Cancer41 topic
  13. Taxanes41 topic
  14. Thyroid Nodules41 topic
  15. NAFLD31 topic
  16. NASH31 topic
  17. Cancer Genomics21 topic
  18. Cytochrome P45021 topic
  19. Mutational Signatures21 topic
  20. Pharmacogenetics21 topic

Where does Begoña de las Heras work?

Begoña de las Heras's main affiliation in the publication record is Eisai (United Kingdom), United Kingdom.

How many publications and citations does Begoña de las Heras have?

OpenAlex counts 48 works and 2,657 citations for Begoña de las Heras, an h-index of 13, ranking #3,209,660 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Begoña de las Heras. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.